TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference
Nov 27, 2023
|
|
TG Therapeutics to Participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) Conference
Nov 03, 2023
|
|
TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
Nov 01, 2023
|
|
TG Therapeutics to Host Conference Call on Third Quarter 2023 Financial Results and Business Update
Oct 30, 2023
|
|
TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
Oct 12, 2023
|
|
TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
Oct 11, 2023
|
|
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
Oct 02, 2023
|
|
TG Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference
Sep 22, 2023
|
|
TG Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Sep 07, 2023
|
|
TG Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
Aug 01, 2023
|
|